selfotel selfotel selfotel (cgs-19755) is a drug which acts as a competitive nmda antagonist, directly competing with glutamate for binding to the receptor. initial studies showed it to have anticonvulsant, anxiolytic, analgesic and neuroprotective effects, and it was originally researched for the treatment of stroke, but subsequent animal and human studies showed phencyclidine-like effects, as well as limited efficacy and evidence for possible neurotoxicity under some conditions, and so clinical development was ultimately discontinued. selfotelclinical dataother namesselfotellegal statuslegal status in general: legal identifiers iupac name (2s,4r)-4-(phosphonomethyl)piperidine-2-carboxylic acid cas number110347-85-8 ypubchem cid68736iuphar/bps4155chemspider61982 nunii4vgj4a41l2keggd02410 ychemblchembl39664 ncomptox dashboard (epa)dtxsid5045675 chemical and physical dataformulac7h14no5pmolar mass223.165 g·mol−13d model (jsmol)interactive image smiles c1cn(c1cp(=o)(o)o)c(=o)o inchi inchi=1s/c7h14no5p/c9-7(10)6-3-5(1-2-8-6)4-14(11,12)13/h5-6,8h,1-4h2,(h,9,10)(h2,11,12,13)/t5-,6+/m1/s1 nkey:lpmrccndngoncd-ritpcoansa-n n ny (what is this?) (verify)